Cellular metabolic state and individual metabolites have been reported to regulate the functional phenotype of immune cells. Cytokine production by regulatory and inflammatory macrophages is thought to mainly involve fatty acid oxidation and glycolysis, respectively, which fuel mitochondrial oxidative phosphorylation. However, the association between metabolic pathways and the acquisition of specific macrophage phenotypes remains unclear. This study assessed the relationship between glycolysis and the differentiation of regulatory macrophages. Human monocytes derived from peripheral blood were cultured in vitro in the presence of macrophage colony-stimulating factor to yield regulatory macrophages (M-Ms). M-Ms had a regulatory macrophage phenotype and produced substantial IL-10 following stimulation with lipopolysaccharide. To analyze the role of glycolysis, glycolysis inhibitors (2-deoxy-dglucose or dichloroacetate) were added during M-M differentiation. These cells cultured with glycolysis inhibitors produced significantly lower amounts of IL-10, but produced significantly higher amounts of IL-6 compared to M-Ms differentiated without glycolysis inhibitors. Such phenotypic change of MMs differentiated with glycolysis inhibitors was associated with the alteration of the gene expression pattern related to macrophage differentiation, such as CSF1, MMP9 and VEGFA. M-Ms differentiated with glycolysis inhibitors seemed to retain plasticity to become IL-10 producing cells. Furthermore, increased level of pyruvate in culture medium was found to partially reverse the effects of glycolysis inhibitors on cytokine production of M-Ms. These results indicate the importance of glycolytic pathway in macrophage differentiation to a regulatory phenotype, and pyruvate may be one of the key metabolites in this process.
Introduction
Macrophages, which are widely distributed in a variety of organs [1] , play important roles in regulating inflammatory responses in a context dependent manner [2] . Phenotypes of macrophages are determined by environmental stimuli. Mirroring the Th1-Th2 polarization of T cells, polarized macrophages are often referred to as inflammatory (M1 or classically activated) and regulatory (M2 or alternatively activated) macrophage [3] . Inflammatory macrophages are involved in anti-microbial responses and express high levels of pro-inflammatory cytokines, including tumor necrosis factor ␣ (TNF-␣), interleukin (IL)-6, IL-12, and IL-23. In contrast, regulatory macrophages are thought to have critical roles in the termination of inflammation by producing the anti-inflammatory cytokine IL-10 [4] [5] [6] [7] [8] . It has also been reported that regulatory macrophages promote tissue repair, contribute to metabolic homeostasis and are involved in immunity against parasitic helminth infections [1, [9] [10] [11] . Metabolic pathways, including oxidative phosphorylation, glycolysis and lipolysis, are actively involved in determining cell fate and in the effector functions of immune cells [12, 13] . Activation of mature inflammatory and regulatory macrophages is characterized by distinct metabolic states. Activation of inflammatory macrophages is dependent on aerobic glycolysis, a process important for the production of reactive oxygen species for host defenses against microbes [14] . In addition, some of the metabolites resulting from glycolysis and the tricarboxylic-acid (TCA) cycle are important in regulating the immunological reactions of inflammatory macrophages [15] [16] [17] . In contrast, activation of regulatory macrophages involves the use of fatty acid oxidation to fuel mitochondrial oxidative phosphorylation [18, 19] .
Although glycolysis has an established role in the activation of inflammatory macrophages, little is known about the association between glycolysis and acquisition of the regulatory macrophage phenotype. Unraveling the relationships between metabolism and the differentiation of regulatory macrophages would have important implications for the homeostatic roles of these cells [1, 2] .
This study therefore analyzed the roles of glycolysis in the in vitro differentiation of human monocytes to regulatory macrophages. Our results suggest that glycolysis is essential for macrophages to differentiate into an IL-10 producing phenotype, and that pyruvate is a key metabolite during the process of regulatory macrophage differentiation.
Materials and methods

In vitro monocyte differentiation
This study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the ethics committees of Keio University School of Medicine (Approval Number; 20090259). Signed informed consent forms were obtained from all donors and all data were analyzed anonymously throughout the study. Ten healthy donors participated in this study. Peripheral blood mononuclear cells collected from healthy donors were isolated from 30 mL of heparinized peripheral blood samples by density gradient centrifugation using LymphoPrep (Nycomed Pharma, Oslo, Norway). Cells were aspirated from the gradient interface, washed with PBS, and resuspended in RPMI-1640 medium (Sigma-Aldrich, St Louis, MO) containing 10% heatinactivated fetal bovine serum (Life Technologies, Carlsbad, CA), 100 U/ml penicillin and 100 mg/ml streptomycin (Life Technologies). Monocytes were purified using a magnetic cell separation system (MACS; Miltenyi Biotec, Auburn, AL) with anti-human CD14 microbeads (Miltenyi Biotec), and were seeded in 6-well plates at 1 × 10 6 cells/well. The culture medium contained 50 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems, Minneapolis, MN) to induce the production of M-CSF differentiated macrophages (M-Ms), or 50 ng/ml M-CSF and 100 ng/ml interferon-gamma (IFN-␥; R&D) to induce the production of M-CSF and IFN-␥ differentiated macrophages (M␥-Ms). Glycolysis was inhibited during differentiation by adding 2-deoxy-d-glucose (2-DG; Sigma-Aldrich) or dichloroacetate (DCA; Sigma-Aldrich) at indicated concentrations. After 6 days, the cells were trypsinized and harvested with a cell scraper; these cells were defined as completely differentiated macrophages.
Stimulation of in vitro differentiated macrophages
The differentiated macrophages described above were seeded in 96-well culture dishes at 1 × 10 5 cells/well and stimulated for 20 h with 100 ng/ml of lipopolysaccharide from Escherichia coli 0111:B4 (LPS; Sigma Aldrich), and the supernatants were collected for cytokine assays. TNF-␣, IL-10, and IL-6 concentrations were measured using a Human Inflammatory Cytokine Kit (Cytometric Beads Assay series; BD Biosciences, San Diego, CA), according to the manufacturer's instructions. The cells were subsequently analyzed using a FACSCalibur system (BD Biosciences).
Quantitative RT-PCR
Total RNA was isolated from macrophages using NucleoSpin RNA kits (Takara Bio Inc., Shiga, Japan). For quantitative RT-PCR, a One-Step PrimeScript RT-PCR Kit (Takara Bio Inc.) was used with specific primers for CCL22, indoleamine 2,3-dioxygenase 1 (IDO1), colony stimulating factor 1 (CSF1), matrix metallopeptidase 9 (MMP9), vascular endothelial growth factor A (VEGFA) and 18S rRNA (Table 1) . PCR amplifications were performed using a CFX96 RealTime System (Bio-Rad Laboratories, Inc., Hercules, CA), and relative expression was determined by normalization to the amplification of the 18S rRNA sequence.
Flow cytometric analysis
Cells were incubated with monoclonal antibodies against CD14, CD33, CD163, CD206, CD209, and HLA-DR and with isotype controls (BioLegend; San Diego, CA). The fluorescence intensity of the labeled cell surface markers was assessed using a FACSCalibur flow cytometer (BD Biosciences), and the data were analyzed using FLOWJO (FlowJo, Ashland, OR) software. Dead cells were excluded from analyses by 7-AAD (BD Biosciences) staining.
Respiratory activity assay
Cellular respiratory activity was measured using XF Mito Stress Test Kits (Seahorse Bioscience, North Billerica, MA) according to the manufacturer's instructions. Oxygen consumption rate (OCR, equal to mitochondrial respiration) was measured using an XF24 analyzer (Seahorse bioscience). Briefly, cells were seeded at 1.6 × 10 5 cells/well the day before the experiment. Basal and maximal respiratory activities were determined. Cellular maximal respiratory activity was determined by adding 0.75 M oligomycin, an inhibitor of complex V (ATP synthase), followed by 0.75 M carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), an uncoupler of mitochondrial oxidative phosphorylation. Gene expression levels from micro array analysis ( Fig. 3 ) are presented as a ratio of normalized intensity (log2). 
Microarray analysis
Total RNA samples were extracted from macrophages using an RNeasy Mini Kit (Qiagen, Hilden, Germany). Equal amounts of RNA from 3 individuals were mixed. The following assays and analyses were performed at Chemical Evaluation and Research Institute (CERI, Tokyo, Japan). RNA was subjected to quality control analysis and reverse transcribed and labeled by using Quick-Amp Labeling Kits (Agilent Technologies, Santa Clara, CA). The labeled cDNA was hybridized to SuperPrint G3 Human GE microarray (8 × 60 K) ver.2 (Agilent Technologies). The microarray was scanned with a DNA Microarray Scanner (Agilent Technologies) and the expression profiles were analyzed with Feature Extraction ver. 10.7.1.1 (Agilent Technologies). Signal intensities were normalized to the mean intensity of all the genes represented on the array. Microarray data are available from the National Center for Biotechnology Information's Gene Expression Omnibus under accession number GSE74182. Canonical pathway analysis was generated using QIA-GEN's Ingenuity Pathway Analysis (IPA ® , QIAGEN Redwood City, www.qiagen.com/ingenuity). Table 3 The 10 genes most down-regulated in 2DG-treated M-M compared with M-M.
Rank
Gene Symbol Gene Name log2 ratio, M+/M− Gene expression levels from micro array analysis (Fig. 3 ) are presented as a ratio of normalized intensity (log2). The canonical pathway analyses were based on micro-array data (Fig. 3 ). Log2 ratios of gene expression were analyzed using Ingenuity Pathway Analysis (IPA ® version 18841524, QIAGEN Redwood City,). P-value expresses the significance of the relationship for the pathway. The numbers of genes whose expression level are changed in each pathway are expressed as "Ratio".
Cellular metabolite analysis
Cellular metabolites were extracted with a methanol containing internal standard solution (Human Metabolome Technologies, Yamagata, Japan). Cationic metabolites were measured by capillary electrophoresis-connected time-of-flight mass spectrometry (CE-TOFMS, Agilent Technologies) and anionic compounds by positive and negative modes of CE-MS/MS (Agilent Technologies).
Statistical analysis
All data are expressed as mean ± SEM. Data were compared using Student's t-test or Dunnett's type multiple comparison test, with p < 0.05 defined as statistically significant.
Results
M-M s have regulatory macrophage phenotypes
Phenotypes of the regulatory macrophages (M-Ms) used in this study were compared to the inflammatory macrophages (M␥-Ms). M-Ms and M␥-Ms were differentiated in vitro from monocytes in the presence of M-CSF and of M-CSF plus IFN-␥, respectively. M-Ms exhibited a spindle-like adhesive morphology, distinct from the spherical and non-adhesive M␥-Ms (Fig. 1A ) [20] . Compared with M␥-Ms, M-Ms expressed significantly higher levels of the regulatory macrophage-related gene, CCL22, and a lower level of the inflammatory macrophage-related gene, IDO1 (Fig. 1B) [21] . M-Ms stimulated with LPS produced larger amounts of the anti-inflammatory cytokine, IL-10, and smaller amounts of the pro-inflammatory cytokines, IL-6 and TNF-␣, than LPS-stimulated M␥-Ms (Fig. 1C) . We also analyzed the metabolic states of macrophages using a Flux analyzer. Regulatory macrophages have been reported to mainly use mitochondrial respiration, whereas inflammatory macrophages have been found to rely on glycolysis [17, 19] . The maximal potential of respiration was higher in M-Ms than in M␥-Ms, suggesting that the former has a metabolic state closer to regulatory macrophages (Fig. 1D) . Taken together, we used M-Ms for the analysis of the differentiation of regulatory macrophages.
Glycolysis inhibition during M-M differentiation alters its characters
To investigate the role of glycolysis during the differentiation of monocytes into regulatory macrophages, M-Ms were incubated with 2-DG or DCA to inhibit glycolysis [22, 23] . 2-DG is phosphorylated by hexokinase, but cannot be further metabolized, resulting in the inhibition of hexokinase. In contrast, DCA inhibits pyruvate dehydrogenase kinase (PDK) by mimicking pyruvate, shifting cellular metabolism from glycolysis to oxidative phosphorylation. As the schematic diagram shown in Fig. 2A , M-Ms were differentiated in the presence of 2-DG or DCA and their phenotypes were determined. Cells differentiated in the presence of 2-DG lost their adhesive phenotype and showed a distinct pattern of cell surface antigens, expressing Siglec-3 (CD33), scavenger receptor (CD163), mannose receptor (CD206), and DC-SIGN (CD209) more strongly, and HLA-DR more weakly, than M-Ms (Fig. 2B, C) as previously reported [20, 24] . The patterns of cell surface antigens of DCAtreated M-Ms were similar to that of M-Ms. M␥-Ms showed different patterns of cell surface antigens from that of M-Ms differentiated with or without 2-DG and DCA. M-Ms differentiated in the presence of 2-DG or DCA showed similar expression of CCL22 to M␥-Ms (Fig. 2D) . Whereas, similar to M-Ms differentiated without 2-DG or DCA, M-Ms differentiated with 2-DG or DCA showed reduced expression of IDO1 compared to M␥-Ms. Furthermore, these M-Ms differentiated in the presence of glycolysis inhibitors produced significantly lower amounts of IL-10, but produced significantly higher amounts of IL-6 and similar amounts of TNF-␣, compared with M-Ms differentiated in the absence of glycolysis inhibitors (Fig. 2E) . It is shown that inhibition of glycolysis during the differentiation of M-Ms results in the loss of their characteristic cytokine production patterns independent of other phenotypes.
Expression of genes essential for macrophage differentiation are affected by glycolysis inhibitors
The gene expression patterns of macrophages were analyzed to understand the mechanism underlying the ability of glycolysis inhibitors to regulate macrophage phenotypes. A microarray analysis identified 2345 probes up-regulated more than 2-fold, and 2284 probes down-regulated less than 0.5-fold, in M-Ms differentiated in the presence than in M-Ms differentiated in the absence of 2-DG (Fig. 3A) . The expression of several genes related to metabolic pathways, such as SLC6A9, ASS1, PSAT1, ASNS and FA2H, differed dramatically in these two cell types (Tables 2 and 3 ). Hierarchical clustering showed that the gene expression pattern 
38/194 (20%)
The canonical pathway analyses were based on micro-array data (Fig. 3) . Log2 ratios of gene expression were analyzed using Ingenuity Pathway Analysis (IPA ® version 18841524, QIAGEN Redwood City,). P-value expresses the significance of the relationship for the pathway. The numbers of genes whose expression level are changed in each pathway are expressed as "Ratio". of 2-DG-treated M-Ms was closer to M-Ms than monocytes and M␥-Ms (Fig. 3B) . Canonical pathway analysis on IPA identified 1524 of the 2345 up-regulated probes and 1657 of the 2282 down-regulated probes in 2-DG-treated M-Ms than in M-Ms. Top 5 pathways significantly up-regulated or down-regulated in ascending order are listed in Tables 4 and 5 . Canonical pathway analysis revealed that 2-DG altered the pathways involved in the regulation of cellular differentiation (hematopoiesis from pluripotent stem cells and dendritic cell maturation) and inflammatory pathways (primary immunodeficiency signaling, T cell receptor signaling, dendritic cell maturation, OX40 (CD134) signaling, allograft rejection signaling, and hepatic fibrosis/hepatic stellate cell activation).
Expression levels of genes related to macrophage differentiation (GO: 0030225) in the microarray were shown in Fig. 3C . The biggest changes were found in the levels of expression of CSF1, MMP9 (decrease) and VEGFA (increase) when expression levels of genes in cultured cells in the presence of 2-DG were compared to differentiated cells in the absence of 2-DG (Fig. 3C) . Quantitative PCR analysis showed that the levels of expression of CSF1 and MMP9 were significantly lower in M-Ms differentiated in the presence than in the absence of 2-DG, with similar results observed when MMs were differentiated in the presence of DCA (Fig. 3D) . The level of expression of VEGFA was up-regulated by glycolysis inhibitors though the increase by 2-DG was not statistically significant.
M-M s differentiated with 2-DG retain plasticity
To test whether glycolysis inhibition affects cell fate permanently, the plasticity of 2-DG-treated M-Ms was assessed (Fig. 4A) . M-Ms were differentiated in the presence of 2-DG for 6 days, then the differentiation medium was changed to the same medium without 2-DG, and culture was continued. On day 11 (5 days after the removal of 2-DG containing culture medium), cells had a spindle-like adhesive phenotype (Fig. 4B ) and produced comparable amounts of IL-10 and IL-6 to those produced by 2-DG-untreated M-Ms, whereas M-Ms differentiated in the presence of 2-DG for 6 days produced significantly smaller amounts of IL-10 and larger amounts of IL-6 compared to 2-DG-untreated M-Ms (Figs. 4C) . These results indicate that M-Ms differentiated for 6 days in the presence of 2-DG are sufficiently plastic to revert to an M-M-like phenotype by 5 days of 2-DG free condition of differentiation.
Pyruvate is a key metabolite for M-M function
We hypothesized that key metabolites which strongly regulate macrophage differentiation may exist in glycolytic pathway. To investigate this hypothesis, we used M-Ms differentiated in the presence of DCA rather than 2-DG, because DCA does not completely shut down the entire flux of glycolytic pathway [23] . We found that the presence of DCA affected the concentration of several metabolites related to the glycolytic pathway and TCA cycle before and after LPS stimulation (Fig. 5A) . Notably, M-Ms differentiated in the presence of DCA showed a marked difference from cells differentiated in the absence of DCA in pyruvate concentration after LPS stimulation (Fig. 5A) . Because DCA promotes pyruvate consumption by accelerating its utilization in the TCA cycle [25, 26] , we focused on pyruvate as a key molecule. To analyze the effect of pyruvate, pyruvate was added to the culture medium during the differentiation of M-Ms, with or without DCA (Fig. 5B) . The addition of pyruvate alone had no effect on the index of functional differentiation of M-Ms, such as the production of IL-6 and IL-10. In contrast, the addition of pyruvate to M-Ms differentiated in the presence of DCA resulted in a significant reduction in IL-6 production, but had no effect on IL-10 production (Fig. 5C) . These results may indicate that the phenotypic changes observed in MMs differentiated in the presence of DCA were due to the effect of pyruvate at least in the property to produce IL-6. 
Discussion
This study investigated the roles of glycolytic pathway in the differentiation of macrophages to a regulatory phenotype, and offered a new insight into the regulation of macrophage differentiation by glycolytic pathway. We found that inhibition of glycolysis during the differentiation of M-Ms resulted in the loss of its regulatory macrophage phenotypes including cytokine production patterns. Remarkably, these effects on cytokine production by glycolysis inhibitors were partially reverted by the addition of pyruvate to the culture medium. Therefore, these results indicate that glycolytic pathway is involved in the differentiation of regulatory macrophages by providing the key metabolite for their differentiation.
Using microarray and quantitative PCR analyses, we revealed the involvement of glycolytic pathway in the regulation of gene expression related to macrophage differentiation. CSF1, which encodes M-CSF, and MMP9 were found to be down-regulated in M-Ms differentiated in the presence of glycolysis inhibitors. Although circulating M-CSF is thought to be secreted by endothelial cells of many organs [27] , it is also locally synthesized by macrophages, mainly its membrane-spanning cell surface form [28] , and locally synthesized M-CSF contributes to the differentiation of macrophages [4, [29] [30] [31] [32] [33] . MMP-9 is preferentially expressed in macrophages and regulates key macrophage functions, such as the angiogenic capacity of M2 macrophages and cellular migration [34, 35] . Down-regulation of M-CSF and MMP-9 by inhibiting glycolysis should have altered the differentiation of M-Ms. On the contrary, up-regulation of VEGFA in M-Ms differentiated in the presence of glycolysis inhibitors might have induced the inflammatory phenotype of M-Ms (increased IL-6 production or comparable gene expression of CCL22 to M␥-Ms), since VEGFA is downstream of NF-B [36] . On the other hand, microarray analysis revealed that the gene expression pattern of M-Ms differentiated in the presence of 2-DG was closer to that of M-Ms than of monocytes, and M␥-Ms differentiated in the presence or absence of 2-DG. Thus, global gene expression pattern suggested that inhibition of glycolysis did not promote differentiation toward an inflammatory, M␥-M-like phenotype. However, detailed investigation of the alteration in global gene expression pattern including the results of canonical pathway analysis should be conducted in the future work.
Macrophages are thought to be highly plastic. Depending on the environmental cues, macrophages can change their phenotype from an inflammatory to a regulatory phenotype and vice versa [37] [38] [39] . Porcheray et al., demonstrated inflammatory and regulatory macrophages were rapidly and fully reversible by treating with a counterstimulatory cytokine [38] . Moreover Das et al., showed that efferocytosis switched macrophages to an anti-inflammatory phenotype through the action of microRNA21 [39] . Plasticity of macrophages is thought to be beneficial and required in circumstances where resolution of inflammation is needed, such as the process of wound healing [37] . Interestingly, the present study indicated that M-Ms differentiated in the presence of a glycolysis inhibitor have sufficient plasticity to become IL-10 producing, M-M-like cells. It may be possible that inhibition of glycolytic pathway reflects the circumstance of malnutrition which is associated with inflammation of whole body or local tissue such as tumors [40] [41] [42] . Collectively, our findings suggest that macrophages may have plasticity to differentiate into a particular phenotype depend-ing not only on the cytokines but also on the metabolic state including the supply of glucose.
Several metabolites, including succinate and lactate, were shown to be involved in regulating cytokine production by macrophages [15, 16] . Also, recent studies have described the antiinflammatory properties of pyruvate or ethyl pyruvate [43, 44] . Ethyl pyruvate is a hyperpermeable analog of pyruvate [45] . These molecules are reported to inhibit the production of proinflammatory cytokines (IL-6, TNF, etc.) from macrophages by acting as an effective scavenger of reactive oxygen species [44, 46] . The present study showed that the addition of pyruvate alone to differentiating M-Ms did not suppress IL-6 production, whereas the addition of pyruvate to M-Ms differentiated in the presence of DCA significantly reduced the production of IL-6 enhanced by DCA. These observations provide a new insight that endogenous pyruvate plays pivotal roles in the differentiation of regulatory macrophages to acquire its characteristic cytokine production pattern. In contrast, pyruvate had no effect on IL-10 production, suggesting the involvement of other metabolites or that the externally added pyruvate was not sufficient for the complete differentiation of M-Ms. Although ethical and technical restriction of using human monocytes makes it difficult to study entire mechanism of our observations, more detailed investigation on the metabolic pathways including activities of regulatory enzymes and levels of key metabolites may reveal the mechanisms how pyruvate and inhibitors affect the differentiation of macrophages.
Recently, Tan et al. reported that mitochondrial respiration which is enhanced by knockdown of PDK1 stimulated M2 activation of macrophages [47] . In this paper, they treated macrophages by IL-4 for several hours to enhance M2 activation, and found that mitochondrial respiration is required for the early activation of M2 macrophages. PDK1 knockdown should have similar effects on the differentiation of macrophages to the addition of DCA which inhibits PDK [23] . However, our study indicated that DCA suppressed the differentiation of macrophages toward regulatory phenotype. In our study, we incubated monocyte with M-CSF for 6 days to differentiate into regulatory macrophages, and evaluated the effect of DCA during the whole period of differentiation. The difference of the protocol and the period of observation between these studies would account for the discrepancy between these findings. That is, DCA might induce the M2 activation of already differentiated macrophages, however, it might inhibit the differentiation of monocyte to a regulatory phenotype.
Treatment of cancers is thought to be enhanced by drugs that modulate metabolic pathways [25, 48] . It may be possible that modulation of macrophage differentiation to a regulatory phenotype by the inhibition of metabolic pathways also contribute to cancer treatment, because tumor associated macrophages exhibit regulatory macrophage phenotype and play critical roles in tumor progression by constituting its microenvironment [49, 50] .
In summary, our results reveal a new aspect of regulatory macrophage differentiation in which glycolytic pathway facilitates this process by supplying pyruvate. Our findings suggest that macrophages will change their phenotype dramatically depending on their circumstances including its metabolic state.
Conclusion
In this study we showed that inhibition of glycolysis during differentiation of regulatory macrophages resulted in a loss of their characteristics including cytokine production patterns and alteration of gene expression patterns relates to macrophage differentiation. These effects were reversed by the addition of pyruvate to the culture media at least in part. It was indicated that glycolytic pathway plays important roles in macrophage differentiation to be a regulatory phenotype, and pyruvate may be one of the key metabolites in this process.
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